These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11526921)

  • 1. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Godet G
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Boldt J
    Lancet; 2001 Aug; 358(9281):581-3. PubMed ID: 11526920
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.
    Schortgen F; Lacherade JC; Bruneel F; Cattaneo I; Hemery F; Lemaire F; Brochard L
    Lancet; 2001 Mar; 357(9260):911-6. PubMed ID: 11289347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hydroxyethyl starch for volume replacement therapy - a swan song?].
    Ittner KP
    Dtsch Med Wochenschr; 2013 Nov; 138(48):2450. PubMed ID: 24254341
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients.
    Leberle R; Ernstberger A; Loibl M; Merkl J; Bunz M; Creutzenberg M; Trabold B
    Injury; 2015 Jan; 46(1):105-9. PubMed ID: 25240412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is fluid resuscitation with high-volume hydroxyethyl starch safe for the kidney in trauma patients?
    Xue FS; Liu GP; Li RP; Sun C
    Injury; 2015 Aug; 46(8):1698-9. PubMed ID: 25823537
    [No Abstract]   [Full Text] [Related]  

  • 8. Starch solutions in Australia: the empire strikes back.
    Bellomo R
    Crit Care Resusc; 2013 Dec; 15(4):253-4. PubMed ID: 24289503
    [No Abstract]   [Full Text] [Related]  

  • 9. Gelatin solutions for critically unwell septic adults.
    Patel A; Brett SJ
    Br J Hosp Med (Lond); 2013 Nov; 74(11):657. PubMed ID: 24220537
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the literature inconclusive about the harm from HES? No.
    Wiedermann CJ; Bellomo R; Perner A
    Intensive Care Med; 2017 Oct; 43(10):1523-1525. PubMed ID: 27007101
    [No Abstract]   [Full Text] [Related]  

  • 11. But is it safe? Hydroxyethyl starch in perioperative care.
    Greenberg S; Tung A
    Anesth Analg; 2015 Mar; 120(3):519-521. PubMed ID: 25695570
    [No Abstract]   [Full Text] [Related]  

  • 12. [Not Available].
    Hahn R
    Lakartidningen; 2018 May; 115():. PubMed ID: 29738050
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient.
    De Labarthe A; Jacobs F; Blot F; Glotz D
    Am J Med; 2001 Oct; 111(5):417-8. PubMed ID: 11599525
    [No Abstract]   [Full Text] [Related]  

  • 14. Is the literature inconclusive about the harm from HES? Yes.
    Ertmer C; Annane D; Van Der Linden P
    Intensive Care Med; 2017 Oct; 43(10):1520-1522. PubMed ID: 27007102
    [No Abstract]   [Full Text] [Related]  

  • 15. Tetrastarch solutions: are they definitely dead?
    Moral V; Aldecoa C; Asuero MS
    Br J Anaesth; 2013 Sep; 111(3):324-7. PubMed ID: 23946355
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients.
    Boldt J; Brosch Ch; Röhm K; Papsdorf M; Mengistu A
    Br J Anaesth; 2008 Apr; 100(4):457-64. PubMed ID: 18305082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl-starch use and PBM: a necessary update to the Italian national guidelines.
    Biancofiore G; Vaglio S; Liumbruno GM
    Blood Transfus; 2016 May; 14(2):195-6. PubMed ID: 27177414
    [No Abstract]   [Full Text] [Related]  

  • 18. Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
    Patel A; Waheed U; Brett SJ
    Intensive Care Med; 2013 Aug; 39(8):1507-8. PubMed ID: 23736140
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of HES, dextran and gelatin on kidney function].
    Vogt N; Brinkmann A; Georgieff M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):268-70. PubMed ID: 9617430
    [No Abstract]   [Full Text] [Related]  

  • 20. "Colloid twice daily" is not fluid resuscitation! Inappropriate inclusion of clinical trials in meta-analyses may distract from gaps in evidence.
    Kranke P; Roewer N; Muellenbach RM
    Intensive Care Med; 2013 Aug; 39(8):1503. PubMed ID: 23736139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.